PL4081531T3 - Kompozycja zawierająca peptydy s-arestyny - Google Patents
Kompozycja zawierająca peptydy s-arestynyInfo
- Publication number
- PL4081531T3 PL4081531T3 PL20828682.3T PL20828682T PL4081531T3 PL 4081531 T3 PL4081531 T3 PL 4081531T3 PL 20828682 T PL20828682 T PL 20828682T PL 4081531 T3 PL4081531 T3 PL 4081531T3
- Authority
- PL
- Poland
- Prior art keywords
- arrestin
- peptides
- composition
- arrestin peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1919222.8A GB201919222D0 (en) | 2019-12-23 | 2019-12-23 | Composition |
| PCT/IB2020/062285 WO2021130653A1 (en) | 2019-12-23 | 2020-12-21 | A composition comprising s-arrestin peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4081531T3 true PL4081531T3 (pl) | 2025-03-31 |
Family
ID=69322844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20828682.3T PL4081531T3 (pl) | 2019-12-23 | 2020-12-21 | Kompozycja zawierająca peptydy s-arestyny |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230203126A1 (pl) |
| EP (1) | EP4081531B1 (pl) |
| JP (1) | JP7778696B2 (pl) |
| KR (1) | KR20220118434A (pl) |
| CN (1) | CN115298195A (pl) |
| AU (1) | AU2020412878A1 (pl) |
| CA (1) | CA3162640A1 (pl) |
| ES (1) | ES3002183T3 (pl) |
| GB (1) | GB201919222D0 (pl) |
| HU (1) | HUE070247T2 (pl) |
| PL (1) | PL4081531T3 (pl) |
| WO (1) | WO2021130653A1 (pl) |
| ZA (1) | ZA202207391B (pl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229489B1 (hu) | 2000-08-21 | 2014-01-28 | Apitope Technology Bristol Ltd | Tolerogén peptidek |
| US20110008382A1 (en) * | 2009-03-07 | 2011-01-13 | Burrows Gregory G | Compositions and methods using recombinant MHC molecules for the treatment of uveitis |
| GB201314052D0 (en) * | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| AU2016275312B2 (en) * | 2015-05-06 | 2021-12-23 | Uti Limited Partnership | Nanoparticle compositions for sustained therapy |
| ES2981555T3 (es) * | 2017-01-04 | 2024-10-09 | Worg Pharmaceuticals Zhejiang Co Ltd | Péptidos de S-arrestina y usos terapéuticos de los mismos |
| GB201700095D0 (en) * | 2017-01-04 | 2017-02-22 | Apitope Int Nv | Composition |
| EP3565585B1 (en) * | 2017-01-04 | 2024-11-13 | Worg Pharmaceuticals (Zhejiang) Co., Ltd. | Therapeutic method using dose escalation protocol for tolerogenic peptides |
| WO2021102182A1 (en) * | 2019-11-19 | 2021-05-27 | Spark Therapeutics, Inc. | Secretable protein induced immune tolerization and treatment of autoimmune, allergic and other diseases and disorders |
-
2019
- 2019-12-23 GB GBGB1919222.8A patent/GB201919222D0/en not_active Ceased
-
2020
- 2020-12-21 JP JP2022538722A patent/JP7778696B2/ja active Active
- 2020-12-21 KR KR1020227021385A patent/KR20220118434A/ko not_active Withdrawn
- 2020-12-21 CN CN202080090048.XA patent/CN115298195A/zh active Pending
- 2020-12-21 HU HUE20828682A patent/HUE070247T2/hu unknown
- 2020-12-21 EP EP20828682.3A patent/EP4081531B1/en active Active
- 2020-12-21 US US17/787,979 patent/US20230203126A1/en active Pending
- 2020-12-21 ES ES20828682T patent/ES3002183T3/es active Active
- 2020-12-21 CA CA3162640A patent/CA3162640A1/en active Pending
- 2020-12-21 PL PL20828682.3T patent/PL4081531T3/pl unknown
- 2020-12-21 AU AU2020412878A patent/AU2020412878A1/en active Pending
- 2020-12-21 WO PCT/IB2020/062285 patent/WO2021130653A1/en not_active Ceased
-
2022
- 2022-07-04 ZA ZA2022/07391A patent/ZA202207391B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7778696B2 (ja) | 2025-12-02 |
| HUE070247T2 (hu) | 2025-05-28 |
| US20230203126A1 (en) | 2023-06-29 |
| EP4081531B1 (en) | 2024-12-04 |
| GB201919222D0 (en) | 2020-02-05 |
| CN115298195A (zh) | 2022-11-04 |
| EP4081531C0 (en) | 2024-12-04 |
| AU2020412878A1 (en) | 2022-07-14 |
| EP4081531A1 (en) | 2022-11-02 |
| ES3002183T3 (en) | 2025-03-06 |
| WO2021130653A1 (en) | 2021-07-01 |
| JP2023508141A (ja) | 2023-03-01 |
| KR20220118434A (ko) | 2022-08-25 |
| ZA202207391B (en) | 2023-09-27 |
| CA3162640A1 (en) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289122A (en) | polypeptides | |
| IL289119A (en) | polypeptides | |
| IL290447A (en) | A pharmaceutical preparation containing ansiphantrine | |
| IL288412A (en) | peptides | |
| IL312556A (en) | New peptides | |
| GB2589063B (en) | A cathode composition | |
| PT3959084T (pt) | Uma composição de borracha | |
| GB2591433B (en) | A cathode composition | |
| GB201900443D0 (en) | Cell-penetrating peptides | |
| IL290019A (en) | Peptides to regulate melanocytes | |
| ZA202204152B (en) | A solubilizing composition | |
| GB201918693D0 (en) | Peptide | |
| GB202117405D0 (en) | Peptide | |
| HUE070247T2 (hu) | S-arresztin peptideket tartalmazó készítmény | |
| GB201906982D0 (en) | Peptides | |
| GB201902850D0 (en) | Antimicroial peptides | |
| GB201918274D0 (en) | A composition | |
| GB201912632D0 (en) | Peptide | |
| GB202113858D0 (en) | Peptides | |
| GB202110693D0 (en) | Peptides | |
| GB201914347D0 (en) | Antimicrobial peptides | |
| GB2588486B (en) | Former | |
| HK40067372A (en) | New peptides | |
| GB202111675D0 (en) | Peptide | |
| HK40074738A (en) | Melanocyte-regulating peptides |